Successful fertility-preserving management using systemic methotrexate and laparoscopic resection of intramural pregnancy following in vitro fertilization and embryo transfer: a case report
article
OA: gold
CC0
AI-generated summary
This case report details successful fertility preservation in an intramural pregnancy following IVF using a staged approach of systemic methotrexate followed by laparoscopic excision.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Intramural pregnancy (IMP) is the rarest form of ectopic pregnancy and lacks an established protocol for its definitive diagnosis and treatment. Its diagnosis remains challenging, as clinicians are often unfamiliar with this condition. Early diagnosis and treatment are crucial to minimize the risk of uterine rupture and to preserve reproductive potential. This report describes the case of a 39-year-old woman (gravida 4, para 0) with a history of repeated dilatation and curettage who developed an intramural ectopic pregnancy following in vitro fertilization and embryo transfer. Initial ultrasound examination revealed an empty gestational sac within the uterine cavity, which was diagnosed as an intrauterine missed abortion. Following an unsuccessful attempt at surgical evacuation, magnetic resonance imaging (MRI) confirmed the diagnosis of IMP. Systemic methotrexate in multiple doses resulted in a gradual decline in serum β-human chorionic gonadotropin (β-hCG) and reduced vascularity on ultrasound. Despite this response, the conceptus persisted, and laparoscopic excision was performed, leading to complete resolution. The patient was discharged 3 days after surgery without complications and was able to resume infertility treatment 3 months postoperatively. This case highlights the effectiveness of a staged therapeutic strategy combining systemic methotrexate and laparoscopic surgery to achieve complete resolution while preserving reproductive potential. This report provides practical insights into optimizing the timing of surgical intervention for fertility-preserving management in this rare and challenging condition.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (16)
- doi:10.1002/uog.26219 via openalex
- doi:10.1093/humrep/des373 via openalex
- doi:10.1016/j.jmig.2013.02.023 via openalex
- doi:10.1016/j.ejogrb.2012.12.036 via openalex
- doi:10.1016/j.jmig.2012.10.005 via openalex
- doi:10.1155/2010/504062 via openalex
- doi:10.1002/jcu.20703 via openalex
- doi:10.1097/aog.0000000000005312 via openalex
- doi:10.1016/j.jmig.2016.05.007 via openalex
- doi:10.1016/j.ejogrb.2020.08.021 via openalex
- doi:10.12998/wjcc.v10.i9.2871 via openalex
- doi:10.1046/j.1469-0705.1999.13020131.x via openalex
- doi:10.1093/hropen/hoaa055 via openalex
- doi:10.1002/jcu.20245 via openalex
- doi:10.1016/j.rbmo.2010.02.022 via openalex
- doi:10.1002/uog.12437 via openalex
SciLite annotations
chemicals 10
methotrexate
methotrexate
methotrexate
methotrexate
methotrexate
methotrexate
gadolinium
methotrexate
carbon dioxide
vasopressin
Source provenance
- openalex
- last seen: 2026-05-13T19:41:03.243940+00:00
- scilite
- last seen: 2026-06-21T06:47:03.627287+00:00
License: CC0
· commercial use OK